Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	279.53	265.72	227.07	198.45	173.25	122.63
Revenue Growth (YoY)	19.42%	17.02%	14.42%	14.55%	41.28%	-1.37%
Cost of Revenue	144.3	133.18	115.1	96.55	84.05	64.23
Gross Profit	135.23	132.54	111.97	101.9	89.2	58.4
Selling, General & Admin	-	13.93	12.09	11.69	9.87	7.82
Other Operating Expenses	56.01	42.08	32.86	33.25	25.77	17.2
Operating Expenses	78.07	76.89	61.93	59.94	49.73	38.57
Operating Income	57.16	55.65	50.04	41.96	39.46	19.83
Interest Expense	-1.45	-1.22	-0.57	-0.42	-0.46	-0.54
Interest & Investment Income	0.3	0.3	0.15	0.07	0	0.01
Earnings From Equity Investments	-0.02	-0.02	-0.01	-0.06	-0.03	0.2
Currency Exchange Gain (Loss)	0.04	0.04	0.01	-0	-0	-
Other Non Operating Income (Expenses)	1.22	1.22	0.07	-0.4	-0.04	-0
EBT Excluding Unusual Items	57.25	55.96	49.68	41.15	38.93	19.51
Asset Writedown	0.03	0.03	-0.03	-0.47	-0.03	-
Other Unusual Items	-	-	-	-	-	0.68
Pretax Income	57.27	55.99	49.65	40.68	38.9	20.19
Income Tax Expense	15.68	14.86	12.92	10.53	10.97	6.05
Earnings From Continuing Operations	41.59	41.14	36.73	30.15	27.93	14.13
Minority Interest in Earnings	-0.93	-0.93	-0.76	-0.63	-0.54	-0.19
Net Income	40.66	40.21	35.97	29.52	27.39	13.94
Net Income to Common	40.66	40.21	35.97	29.52	27.39	13.94
Net Income Growth	10.55%	11.77%	21.86%	7.77%	96.46%	8.96%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change (YoY)	-	-1.85%	-	-	0.01%	-0.01%
EPS (Basic)	2.54	2.51	2.21	1.81	1.68	0.86
EPS (Diluted)	2.54	2.51	2.21	1.81	1.68	0.86
EPS Growth	-	13.88%	21.86%	7.77%	96.43%	8.97%
Free Cash Flow	41.87	36	35.13	39.35	36.28	23.64
Free Cash Flow Per Share	2.62	2.25	2.15	2.41	2.23	1.45
Dividend Per Share	-	1.570	1.570	1.300	1.030	0.552
Dividend Growth	-	-	20.77%	26.21%	86.59%	-
Gross Margin	48.38%	49.88%	49.31%	51.35%	51.49%	47.62%
Operating Margin	20.45%	20.94%	22.04%	21.14%	22.78%	16.17%
Profit Margin	14.55%	15.13%	15.84%	14.88%	15.81%	11.37%
Free Cash Flow Margin	14.98%	13.55%	15.47%	19.83%	20.94%	19.28%
EBITDA	79.22	75.63	66.5	56.76	53.35	33.21
EBITDA Margin	28.34%	28.46%	29.29%	28.60%	30.80%	27.08%
D&A For EBITDA	22.05	19.98	16.46	14.8	13.89	13.38
EBIT	57.16	55.65	50.04	41.96	39.46	19.83
EBIT Margin	20.45%	20.94%	22.04%	21.14%	22.78%	16.17%
Effective Tax Rate	27.38%	26.53%	26.02%	25.89%	28.19%	29.99%
Advertising Expenses	-	12.14	10.31	9.86	8.42	5.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.